THE ROLE OF MOLECULAR PROFILING IN SELECTING A COMBINED TREATMENT STRATEGY FOR EPITHELIAL OVARIAN CANCER
Acta Medica Leopoliensia · 22.12.2025 · 31 (3-4) · 138-152
DOI: 10.25040/aml2025.3-4.138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Medica Leopoliensia, online erschienen am 22.12.2025. Verfasst von Iryna Hrytsay und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
To investigate the impact of molecular profiling on the choice of combined treatment strategy and clinical outcomes in patients with epithelial ovarian cancer. Materials and Methods. The study included 88 patients with stage IIIC-IV epithelial ovarian cancer, divided into two groups. In the first group (n=44), immunohistochemical and molecular genetic profiling was performed to determine HRD status and mutations in the BRCA1/2 and TP53 genes, in addition to standard clinical and instrumental examinations. Based on these results, an individualized treatment strategy was developed and implemented. In the second group (n=44), without molecular profiling, the standard treatment regimen was applied without molecular profiling. The groups were comparable in age, stages, and histological tumor subtypes. Treatment efficacy was assessed by computed tomography (CT) 3 months after treatment, and survival analysis was performed using the Kaplan-Meier method.
Results
Personalized selection of treatment strategy led to improved survival. The recurrence rate was significantly lower in patients with molecular profiling (61.36% versus 84.09%, p=0.02). Absence of radiological signs of recurrence on CT was more frequently observed in the first group (45.45% versus 20.45%, p=0.013), whereas disease progression predominated in the second group. Five-year survival in the molecular profiling group was 63% compared to 33% in the standard treatment group, with a median survival of 95 and 36 months, respectively (p
Zitieren
APA
Hrytsay, I., & Volodko, N. (2025). THE ROLE OF MOLECULAR PROFILING IN SELECTING A COMBINED TREATMENT STRATEGY FOR EPITHELIAL OVARIAN CANCER. Acta Medica Leopoliensia, 31(3-4), 138-152. https://doi.org/10.25040/aml2025.3-4.138
Vancouver
Hrytsay I, Volodko N. THE ROLE OF MOLECULAR PROFILING IN SELECTING A COMBINED TREATMENT STRATEGY FOR EPITHELIAL OVARIAN CANCER. Acta Medica Leopoliensia. 2025;31(3-4):138-152. doi:10.25040/aml2025.3-4.138
BibTeX
@article{Hrytsay2025,
author = {Hrytsay, Iryna and Volodko, Nataliia},
title = {THE ROLE OF MOLECULAR PROFILING IN SELECTING A COMBINED TREATMENT STRATEGY FOR EPITHELIAL OVARIAN CANCER},
journal = {Acta Medica Leopoliensia},
year = {2025},
volume = {31},
number = {3-4},
pages = {138--152},
doi = {10.25040/aml2025.3-4.138}
}
EUVIMED